Cargando…
Risk of Macrophage Activation Syndrome in Patients with Adult-Onset Still’s Disease Treated with IL-1 and IL-6 Inhibitors: A Meta-analysis and Single-Center Experience
INTRODUCTION: Patients with adult-onset Still’s disease (AOSD) are at risk of developing macrophage activation syndrome (MAS), a life-threatening condition. Some cases of MAS have been reported following the use of biological agents, highlighting the need to identify contributing factors. This study...
Autores principales: | Adachi, Soichiro, Takase-Minegishi, Kaoru, Maeda, Ayaka, Nagai, Hideto, Horita, Nobuyuki, Yoshimi, Ryusuke, Kirino, Yohei, Nakajima, Hideaki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10654298/ https://www.ncbi.nlm.nih.gov/pubmed/37794210 http://dx.doi.org/10.1007/s40744-023-00600-x |
Ejemplares similares
-
Incidence and Distinct Features of Immune Checkpoint Inhibitor-Related Myositis From Idiopathic Inflammatory Myositis: A Single-Center Experience With Systematic Literature Review and Meta-Analysis
por: Hamada, Naoki, et al.
Publicado: (2021) -
Case Report: Tocilizumab Treatment for VEXAS Syndrome With Relapsing Polychondritis: A Single-Center, 1-Year Longitudinal Observational Study In Japan
por: Kunishita, Yosuke, et al.
Publicado: (2022) -
The Roles of Monocytes and Macrophages in Behçet’s Disease With Focus on M1 and M2 Polarization
por: Hirahara, Lisa, et al.
Publicado: (2022) -
Incidence and Risk of Hematological Adverse Events Associated With Immune Checkpoint Inhibitors: A Systematic Literature Review and Meta-Analysis
por: Ohashi, Takuma, et al.
Publicado: (2023) -
GWAS-identified CCR1 and IL10 loci contribute to M1 macrophage-predominant inflammation in Behçet’s disease
por: Nakano, Hiroto, et al.
Publicado: (2018)